# Placebo-Controlled Trial of Safety and Efficacy of Thalidomide in Patients With Infections Due to Mycobacterium and/or HIV

> **NCT00002104** · PHASE1 · COMPLETED · sponsor: **Aaron Diamond AIDS Research Center**

## Conditions studied

- Mycobacterium Avium-Intracellulare Infection
- HIV Infections
- Tuberculosis, Mycobacterium Infection

## Interventions

- **DRUG:** Thalidomide

## Key facts

- **NCT ID:** NCT00002104
- **Lead sponsor:** Aaron Diamond AIDS Research Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2005-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002104

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002104, "Placebo-Controlled Trial of Safety and Efficacy of Thalidomide in Patients With Infections Due to Mycobacterium and/or HIV". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00002104. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*